Dosage and administration Anti-egfr therapeutics
MA39599AUndetermined Publication Date: 2016-10-05MERRIMACK PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA39599
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2014-05-30
- Filing Date
- 2015-05-13
- Publication Date
- 2016-10-05
Abstract
Methods for optimizing a therapeutic response in a patient (
Need to check novelty before this filing date? Find Prior Art